A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia. (Q40455631)
Jump to navigation
Jump to search
scientific article published on 9 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia. |
scientific article published on 9 March 2007 |
Statements
1 reference
A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia. (English)
1 reference
Pierre Fenaux
1 reference
Bob Lowenberg
1 reference
Jean-Luc Harousseau
1 reference
Jeffrey E Lancet
1 reference
Josy Reiffers
1 reference
Xavier Thomas
1 reference
Francoise Huguet
1 reference
Steven Zhang
1 reference
Wayne Rackoff
1 reference
Peter De Porre
1 reference
Richard Stone
1 reference
Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group
1 reference
9 March 2007
1 reference
Identifiers
1 reference